7 key points from the new testosterone prescribing guidance

THE Endocrine Society of Australia has released a position statement on testosterone.

Part one is published in the MJA today.

1. Pathological hypogonadism confirmed by hormonal tests (total T, LH, FSH) is the only condition for which there is good evidence of a benefit of testosterone replacement therapy
2. Mass spectrometry is most accurate and preferred over immunoassays
3. Pathological hypogonadism can present in many ways including psychosexual symptoms or unexplained osteoporosis, anaemia or reduced muscle mass
4. Evidence is lacking for testosterone